Home Table of Contents

§ 13-3502. Co-prescribing of opioid overdose reversal drugs

West's Annotated Code of MarylandHealth--GeneralEffective: June 1, 2017

West's Annotated Code of Maryland
Health--General
Title 13. Miscellaneous Health Care Programs (Refs & Annos)
Subtitle 35. CO-Prescribing of Opioid Overdose Reversal Drugs (Refs & Annos)
Effective: June 1, 2017
MD Code, Health - General, § 13-3502
§ 13-3502. Co-prescribing of opioid overdose reversal drugs
Currentness
Establishment of guidelines
(a) The Secretary shall establish guidelines for the co-prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21-2A-01 of this article.
Contents of guidelines
(b) The guidelines established under subsection (a) of this section shall address the co-prescribing of opioid overdose reversal drugs for patients who are:
(1) At an elevated risk of overdose; and
(2)(i) Receiving opioid therapy for chronic pain;
(ii) Receiving a prescription for benzodiazepines; or
(iii) Being treated for opioid use disorders.

Credits

Added by Acts 2017, c. 571, § 1, eff. June 1, 2017; Acts 2017, c. 572, § 1, eff. June 1, 2017.
MD Code, Health - General, § 13-3502, MD HEALTH GEN § 13-3502
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document